1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Cystic Fibrosis Lung: new trials by email Literature Review of Cystic Fibrosis Lung trials Research Report on Cystic Fibrosis Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic | Phase 1 / Phase 2 | Completed | Respirion Pharmaceuticals Pty Ltd | 71 | 2024-04-01 | 2026-06-25 |
| 4D-710 in Adult Patients With Cystic Fibrosis 4D-710 - Cystic Fibrosis Lung | Phase 2 | Recruiting | 4D Molecular Therapeutics | 30 | 2022-03-29 | 2026-07-06 |
Cystic Fibrosis (2) · Bronchiolitis Obliterans Syndrome (1) · Pseudomonas Infections (1) · Recurrence (1) · Respiratory Tract Infections (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Genetic Diseases, Inborn (2) · Infant, Newborn, Diseases (2) · Lung Diseases (2) · Pancreatic Diseases (2) · Respiratory Tract Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Disease Attributes (1) · Graft vs Host Disease (1)
4D Molecular Therapeutics (1) · Respirion Pharmaceuticals Pty Ltd (1)
United States (2) · Australia (1)
Sam Moskowitz MD (1)